Add Up The Parts: VONE Could Be Worth $257
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 01 2024
0mins
Should l Buy ALGN?
Source: NASDAQ.COM
- Analyst Target Prices for ETFs: Analysts have compared the trading prices of ETF holdings against 12-month forward target prices to determine the weighted average implied analyst target price for the Vanguard Russell 1000 ETF (VONE), which is $257.38 per unit.
- Upside Potential: VONE has a 12.72% upside potential based on the average analyst targets of its underlying holdings, including Molson Coors Beverage Co (TAP), Align Technology Inc (ALGN), and F5 Inc (FFIV).
- Notable Upside Stocks: TAP has an 18.10% upside, ALGN has a 16.61% upside, and FFIV has a 16.35% upside according to average analyst target prices compared to recent share prices.
- Analyst Justification: Questions arise about whether analysts are justified in their targets or overly optimistic, prompting the need for further investor research to understand if targets align with company and industry developments.
- Additional Information: The article also mentions other topics like stocks crossing above their 200-day moving average, UBFO market cap history, and SSFN YTD return, while noting that views expressed are those of the author and not necessarily Nasdaq, Inc.'s.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 173.940
Low
169.00
Averages
198.70
High
220.00
Current: 173.940
Low
169.00
Averages
198.70
High
220.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Align Technology Plans $200 Million Stock Buyback
- Buyback Program Initiation: Align Technology has announced a plan to repurchase $200 million of its common stock through open market transactions, reflecting management and the Board's confidence in the company's long-term strategy and growth opportunities, which is expected to enhance shareholder value.
- Clear Funding Source: The buyback will be executed under Align's existing $1 billion stock repurchase program, with approximately $1.06 billion in cash and cash equivalents as of March 31, 2026, ensuring ample funding for the repurchase.
- Market Condition Assessment: The timing and number of shares repurchased will be evaluated based on market conditions, stock price, and trading volume, demonstrating the company's flexibility and prudence in executing the buyback.
- Long-Term Strategic Execution: Align emphasizes its commitment to focusing on strategic priorities, delivering meaningful outcomes for doctors and patients, and creating long-term shareholder value through sustainable growth and performance, showcasing its leadership in the digital dentistry space.
See More
Align Technology Showcases Latest Innovations in Invisalign at AAO 2026
- Digital Treatment Planning Innovation: Align Technology showcased the latest Invisalign® system and iTero Lumina™ scanners at AAO 2026, emphasizing continuous innovation in digital treatment planning and 3D printing, aimed at enhancing clinical quality and treatment experience, thereby improving efficiency for practitioners and satisfaction for patients.
- Specifix™ Attachment System: The newly launched Invisalign Specifix™ Attachment System utilizes 3D printing to reduce variability in attachment size and placement, streamlining the attachment workflow, which is expected to enhance predictability and efficiency in treatment, further driving the adoption of digital workflows.
- Integrated Buttons and Expanders: The Invisalign integrated buttons and Palatal Expander with integrated hooks are designed to provide doctors with more flexible treatment options, enabling them to effectively manage complex cases while enhancing patient comfort and treatment outcomes, aligning with market demands for personalized care.
- Clinical Education and Support: Align is offering over 24 hours of clinical education during the AAO event, led by top orthodontists, aimed at enhancing practitioners' understanding and application of new technologies, thereby promoting overall industry advancement.
See More
Align Showcases Digital Innovations at AAO 2026
- Digital Platform Innovation: Align showcased advancements in its digital platform at AAO 2026, including the Invisalign Specifix™ Attachment System, designed to reduce variability in attachment placement and size through 3D printing, thereby enhancing clinical efficiency and patient experience.
- New Product Preview: The newly launched Invisalign integrated buttons and Palatal Expander with integrated hooks provide doctors with more flexible and precise bite correction options, expected to significantly improve treatment outcomes and patient satisfaction.
- Clinical Education Enhancement: Align offers over 24 hours of clinical education during the event, led by top orthodontists, aimed at enhancing doctors' understanding and application of new technologies, thus driving overall industry advancement.
- Market Leadership: Through ongoing investments in digital manufacturing and 3D printing, Align ensures high-quality Invisalign aligner production capabilities at a global scale, further solidifying its leadership position in the digital orthodontics sector.
See More
Align Technology Reports Strong Q1 2026 Earnings with Record Clear Aligner Shipments
- Strong Performance: Align Technology reported total revenues of $1.041 billion for Q1 2026, with an overall gross margin of 70.8%, reflecting a 1.4 percentage point year-over-year increase, indicating robust market performance and improved profitability.
- Record Clear Aligner Shipments: The company achieved a record shipment of 686,000 Clear Aligners in Q1, with 449,000 adults and 237,000 teens and kids treated, demonstrating sustained strong demand in the global market.
- Cautious Future Outlook: Align expects Q2 2026 worldwide revenues to range from $1.04 billion to $1.06 billion, while acknowledging potential impacts from ongoing military actions in the Middle East, yet maintaining a full-year revenue growth forecast of 3% to 4%.
- Stock Buyback Plan: The company announced plans to repurchase up to an additional $200 million of its common stock starting around May 1, 2026, reflecting confidence in its stock value and providing additional returns to shareholders.
See More
Align (ALGN) Q1 2026 Earnings Call Transcript
See More
Align Technology Set to Announce Q1 Earnings on April 29
- Earnings Announcement: Align Technology (ALGN) is set to release its Q1 2023 earnings report on April 29 after market close, with consensus EPS estimated at $2.29, reflecting a 7.5% year-over-year increase, which could directly impact the stock price.
- Revenue Expectations: The revenue forecast for Q1 stands at $1.02 billion, representing a 4.2% year-over-year growth, and achieving this target would further solidify the company's position in the market, particularly regarding its international growth potential.
- Historical Performance Review: Over the past two years, ALGN has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a level of stability in profitability that may bolster investor confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 2 upward revisions and 8 downward adjustments, while revenue estimates experienced 6 upward revisions and 1 downward adjustment, reflecting varying market perceptions regarding the company's future performance.
See More
Align Technology Plans $200 Million Stock Buyback
- Buyback Program Initiation: Align Technology has announced a plan to repurchase $200 million of its common stock through open market transactions, reflecting management and the Board's confidence in the company's long-term strategy and growth opportunities, which is expected to enhance shareholder value.
- Clear Funding Source: The buyback will be executed under Align's existing $1 billion stock repurchase program, with approximately $1.06 billion in cash and cash equivalents as of March 31, 2026, ensuring ample funding for the repurchase.
- Market Condition Assessment: The timing and number of shares repurchased will be evaluated based on market conditions, stock price, and trading volume, demonstrating the company's flexibility and prudence in executing the buyback.
- Long-Term Strategic Execution: Align emphasizes its commitment to focusing on strategic priorities, delivering meaningful outcomes for doctors and patients, and creating long-term shareholder value through sustainable growth and performance, showcasing its leadership in the digital dentistry space.
See More
Align Technology Showcases Latest Innovations in Invisalign at AAO 2026
- Digital Treatment Planning Innovation: Align Technology showcased the latest Invisalign® system and iTero Lumina™ scanners at AAO 2026, emphasizing continuous innovation in digital treatment planning and 3D printing, aimed at enhancing clinical quality and treatment experience, thereby improving efficiency for practitioners and satisfaction for patients.
- Specifix™ Attachment System: The newly launched Invisalign Specifix™ Attachment System utilizes 3D printing to reduce variability in attachment size and placement, streamlining the attachment workflow, which is expected to enhance predictability and efficiency in treatment, further driving the adoption of digital workflows.
- Integrated Buttons and Expanders: The Invisalign integrated buttons and Palatal Expander with integrated hooks are designed to provide doctors with more flexible treatment options, enabling them to effectively manage complex cases while enhancing patient comfort and treatment outcomes, aligning with market demands for personalized care.
- Clinical Education and Support: Align is offering over 24 hours of clinical education during the AAO event, led by top orthodontists, aimed at enhancing practitioners' understanding and application of new technologies, thereby promoting overall industry advancement.
See More
Align Showcases Digital Innovations at AAO 2026
- Digital Platform Innovation: Align showcased advancements in its digital platform at AAO 2026, including the Invisalign Specifix™ Attachment System, designed to reduce variability in attachment placement and size through 3D printing, thereby enhancing clinical efficiency and patient experience.
- New Product Preview: The newly launched Invisalign integrated buttons and Palatal Expander with integrated hooks provide doctors with more flexible and precise bite correction options, expected to significantly improve treatment outcomes and patient satisfaction.
- Clinical Education Enhancement: Align offers over 24 hours of clinical education during the event, led by top orthodontists, aimed at enhancing doctors' understanding and application of new technologies, thus driving overall industry advancement.
- Market Leadership: Through ongoing investments in digital manufacturing and 3D printing, Align ensures high-quality Invisalign aligner production capabilities at a global scale, further solidifying its leadership position in the digital orthodontics sector.
See More
Align Technology Reports Strong Q1 2026 Earnings with Record Clear Aligner Shipments
- Strong Performance: Align Technology reported total revenues of $1.041 billion for Q1 2026, with an overall gross margin of 70.8%, reflecting a 1.4 percentage point year-over-year increase, indicating robust market performance and improved profitability.
- Record Clear Aligner Shipments: The company achieved a record shipment of 686,000 Clear Aligners in Q1, with 449,000 adults and 237,000 teens and kids treated, demonstrating sustained strong demand in the global market.
- Cautious Future Outlook: Align expects Q2 2026 worldwide revenues to range from $1.04 billion to $1.06 billion, while acknowledging potential impacts from ongoing military actions in the Middle East, yet maintaining a full-year revenue growth forecast of 3% to 4%.
- Stock Buyback Plan: The company announced plans to repurchase up to an additional $200 million of its common stock starting around May 1, 2026, reflecting confidence in its stock value and providing additional returns to shareholders.
See More
Align (ALGN) Q1 2026 Earnings Call Transcript
See More
Align Technology Set to Announce Q1 Earnings on April 29
- Earnings Announcement: Align Technology (ALGN) is set to release its Q1 2023 earnings report on April 29 after market close, with consensus EPS estimated at $2.29, reflecting a 7.5% year-over-year increase, which could directly impact the stock price.
- Revenue Expectations: The revenue forecast for Q1 stands at $1.02 billion, representing a 4.2% year-over-year growth, and achieving this target would further solidify the company's position in the market, particularly regarding its international growth potential.
- Historical Performance Review: Over the past two years, ALGN has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a level of stability in profitability that may bolster investor confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 2 upward revisions and 8 downward adjustments, while revenue estimates experienced 6 upward revisions and 1 downward adjustment, reflecting varying market perceptions regarding the company's future performance.
See More
